TWi T085 225 Pill: white, capsule/oblong, 19mm
The pill with imprint TWi T085 225 (White, Capsule/Oblong, 19mm) has been identified as Propafenone Hydrochloride Extended-Release 225 mg and is used for Atrial Fibrillation, Ventricular Tachycardia, Atrial Flutter, and Wolff-Parkinson-White Syndrome. It belongs to the drug class group I antiarrhythmics and is not a controlled substance.
Images for TWi T085 225
Propafenone Hydrochloride Extended-Release
- Imprint
- TWi T085 225
- Strength
- 225 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TWi Pharmaceuticals USA, Inc.
- Manufacturer
- TWi Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 24979-0085 (Discontinued)
See also:
More about propafenone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (71)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.